Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffry P Simko

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Magnetic Resonance Imaging|October 19, 2021
Identification of prostate cancer using multiparametric MR imaging characteristics of prostate tissues referenced to whole mount histopathologyMatthew Gibbons, Olga Starobinets, Jeffry P Simko, et al.
Magnetic Resonance Imaging|September 11, 2024
The impact of benign tissue within cancerous regions in the prostate: Characterizing sparse and dense prostate cancers on whole-mount histopathology and on multiparametric MRIOlga Starobinets, Jeffry P Simko, Matthew Gibbons, et al.
Annals of Diagnostic Pathology|August 24, 2024
Next-generation sequencing has diagnostic utility in challenging small/flat urothelial lesionsAmélie Pinard, Constance Chen, Jessica Van Ziffle, et al.
Brachytherapy|December 24, 2014
Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapyDavid R Raleigh, I-Chow Hsu, Steve Braunstein, et al.
Plos One|June 20, 2019
TP53 structural variants in metastatic prostatic carcinomaDeepika Sirohi, Patrick Devine, James P Grenert, et al.
AJR. American Journal of Roentgenology|August 22, 2009
Mucinous adenocarcinoma of the prostate: MRI and MR spectroscopy featuresAntonio C Westphalen, Fergus V Coakley, John Kurhanewicz, et al.
The American Journal of Surgical Pathology|August 13, 2011
Metastatic melanoma with striking adenocarcinomatous differentiation illustrating phenotypic plasticity in melanomaJohn R Jalas, Swapna Vemula, Vladimir Bezrookove, et al.
Histopathology|November 27, 2023
Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancerNancy Y Greenland, Janet E Cowan, Bradley A Stohr, et al.
The Journal of Urology|February 28, 2019
Correlation of a Commercial Genomic Risk Classifier with Histological Patterns in Prostate CancerNancy Y Greenland, Li Zhang, Janet E Cowan, et al.
The Prostate|September 18, 2020
Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk categoryNancy Y Greenland, Janet E Cowan, Emily Chan, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Magnetic Resonance Imaging|October 19, 2021
Identification of prostate cancer using multiparametric MR imaging characteristics of prostate tissues referenced to whole mount histopathologyMatthew Gibbons, Olga Starobinets, Jeffry P Simko, et al.
Magnetic Resonance Imaging|September 11, 2024
The impact of benign tissue within cancerous regions in the prostate: Characterizing sparse and dense prostate cancers on whole-mount histopathology and on multiparametric MRIOlga Starobinets, Jeffry P Simko, Matthew Gibbons, et al.
Annals of Diagnostic Pathology|August 24, 2024
Next-generation sequencing has diagnostic utility in challenging small/flat urothelial lesionsAmélie Pinard, Constance Chen, Jessica Van Ziffle, et al.
Brachytherapy|December 24, 2014
Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapyDavid R Raleigh, I-Chow Hsu, Steve Braunstein, et al.
Plos One|June 20, 2019
TP53 structural variants in metastatic prostatic carcinomaDeepika Sirohi, Patrick Devine, James P Grenert, et al.
AJR. American Journal of Roentgenology|August 22, 2009
Mucinous adenocarcinoma of the prostate: MRI and MR spectroscopy featuresAntonio C Westphalen, Fergus V Coakley, John Kurhanewicz, et al.
The American Journal of Surgical Pathology|August 13, 2011
Metastatic melanoma with striking adenocarcinomatous differentiation illustrating phenotypic plasticity in melanomaJohn R Jalas, Swapna Vemula, Vladimir Bezrookove, et al.
Histopathology|November 27, 2023
Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancerNancy Y Greenland, Janet E Cowan, Bradley A Stohr, et al.
The Journal of Urology|February 28, 2019
Correlation of a Commercial Genomic Risk Classifier with Histological Patterns in Prostate CancerNancy Y Greenland, Li Zhang, Janet E Cowan, et al.
The Prostate|September 18, 2020
Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk categoryNancy Y Greenland, Janet E Cowan, Emily Chan, et al.
Pageof 10